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The pivotal role of MBD4–ATP7B in the human
Cu(I) excretion path as revealed by EPR
experiments and all-atom simulations†
Zena Qasem,‡a Matic Pavlin,‡b Ida Ritacco,b Lada Gevorkyan-Airapetov,a
Alessandra Magistrato *b and Sharon Ruthstein *a
Copper’s essentiality and toxicity require a meticulous mechanism for its acquisition, cellular distribution
and excretion, which remains hitherto elusive. Herein, we jointly employed electron paramagnetic
resonance spectroscopy and all-atom simulations to resolve the copper trafficking mechanism in
humans considering the route travelled by Cu(I) from the metallochaperone Atox1 to the metal binding
domains 3 and 4 of ATP7B. Our study shows that Cu(I) in the final part of its extraction pathway is most
likely mediated by binding of Atox1 monomer to MBD4 of ATP7B. This interaction takes place through
weak metal-stabilized protein–protein interactions.
Significance to metallomics
Combined use of EPR measurements and MD simulations succeeded in showing that the Cu(I) extrusion path is most likely mediated by Atox1 binding to MBD4 of
ATP7B. Efficient Cu(I) trafficking must rely on a subtle balance of transient interactions and appropriate conformational selection of the metallochaperone and its
partner ATPase, which only MDB4 satisfies. In addition, this research stresses the significance of monitoring the structural flexibility of a biological system in
solution, and of integrating these data with atomic-level information, in order to disclose the exact role of a protein in biological pathways.
Introduction
Copper is an essential, yet toxic, metal ion for cells. Hence, its
free amount must be strictly limited. In human cells, one of the
pathways tightly controlling the in-cell copper (Cu(I)) concen-
tration involves three proteins: (i) the Ctr1 Cu(I) transporter,
which reduces dietary Cu(II) (accumulated from the blood-
stream) to Cu(I) and transfers it to its cytoplasmic domain,1–3
(ii) the metallochaperone Atox1, which delivers Cu(I) ion from
Ctr1 to ATP7A/B in the Golgi,4,5 and (iii) ATP7A/B, which either
transports Cu(I) to the secretory pathway, where these ions are
incorporated into copper-dependent enzymes, or exports it out of
the cell.6,7 Hence, these transporters, by establishing transient
protein–protein interactions, evolved to tightly regulate Cu(I)’s
cellular needs while minimizing its toxic effects. Pathological
mutations in ATP7A and ATP7B proteins alter normal Cu(I)
distribution, leading to severe human pathologies (Menkes and
Wilson’s disease, neurodegeneration, and cancer).8 At the end of
the transport route, Atox1 interacts with the N-terminal domain of
ATP7A/B, which contains six metal-binding domains (MBDs)
connected by linkers. Each MBD (B7 kDa) has a ferredoxin-like
fold with a compact babbab structure and a conserved metal-
binding motif MXCXXC (X stands for any amino acid), located in
the solvent-exposed b1–a1 loop (also called a Cu loop), which
binds Cu(I) ions. Atox1 is a small soluble cytosolic Cu(I) receptor,
structured in the same babbab motif of MBDs from ATP7A/B.9,10
The structural similarity between the chaperone and the target
proteins is a hallmark of Cu(I) transporters.
In the last decade, distinct biophysical tools have been used to
characterize the interaction between Atox1 and the six MBDs of
ATP7A/B, sometimes leading to contradictory conclusions.11–13
Nuclear magnetic resonance (NMR) studies disclosed that the six
MBDs can be differentiated into two units, comprising MBD1–3 and
MBD5–6, whereas MBD4 serves as a linker between them.11,14,15
Cu(I) binding to MBD1–4 stimulates its transport by ATP7A and
presumably facilitates Cu(I) trafficking.16 The structures of MBD3
and MBD4, and their relative spatial arrangement were also solved
by NMR.17,18 NMR studies and classical molecular dynamics (MD)
simulations indicated that Atox1 can bind to MBD4, but not to
MBD3.4,19 Single-molecule FRET (smFRET) experiments
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succeeded in reporting a dynamic situation, where Atox1 can
coordinate both MBD3, MBD4, and the two domains simulta-
neously, MBD3–4.20 In these experiments Atox1 interacted with
MBDs as a monomer.5,16 Notably, different structural models of
the Atox1–MBD heterodimer were suggested (Fig. 1): (i) Atox1
interacts ‘‘face-to-face’’ with MBD with the two a helices of each
protein pointing to each other. Here, one Atox1 monomer
interacts with one MBD at a time. (ii) A ‘‘back-to-face’’ model,
where Atox1 is sandwiched between two MBDs. Namely, Atox1
points to one MBD with its a1 helix, while interacting with
the other via its b2 and b3 sheets.17,20 In this scenario, the
identity of the MBD and its interaction mode with Atox1 remain
elusive.
In the last few years we have investigated the Cu(I) trafficking
mechanism by electron paramagnetic resonance (EPR) spectro-
scopy. This technique complements NMR and smFRET studies,
owing to its sensitivity to the proteins’ conformational flexibility
in solution. For example, EPR experiments recently showed that
Atox1 can accommodate distinct conformations, depending on
the interacting partner protein,21–23 and that it interacts as a
homodimer with the Ctr1 intracellular domains. Conversely, all-
atom simulations have the potential to rationalize at the atomic-
level resolution the spectroscopic findings. Aiming at clarifying
the way and the identity of the MBD of ATP7B involved in the
Cu(I) excretion path, we concomitantly employed EPR spectro-
scopy and all-atom MD simulations.
Materials and methods
Cloning, expression and purification of ATP7B3–4 metal
binding domains
The ATP7B3–4 metal binding domains’ (MBD3–4) gene was
first amplified by PCR using primers containing specific ATP7B
MBD3–4 sequences and flanking regions corresponding to the
expression vector sequences pTYB12.
The forward primer of ATP7B MBD3–4:
50-GTTGTACAGAATGCTGGTCATATGAGACCTTTATCTTCTGCT
AAC-30
Reverse primer of ATP7B MBD3–4:
50-GTCACCCGGGCTCGAGGAATTTCAGTGGTTTCCAAGAGGGTT
AGT-30
This amplicon was cloned into the pTYB12 vector by restriction-
free cloning.24
pTYB12 is a cloning and expression vector that allows the
overexpression of the ATP7B MBD3–4 as a fusion to a self-
cleavable intein tag. The self-cleavage activity of the intein
allows the release of ATP7B MBD3–4 from the chitin-bound
intein tag. The clone was expressed in E. coli strain Origami 2.
The starter from stock glycerol was grown at 37 1C to an optical
density of 0.5–0.6 (OD600) using terrific broth (TB) medium
supplemented with ampicillin and tetracycline as selection
factors, then induced with 1 mM isopropyl-b-D-thiogalacto-
pyranoside (IPTG) at 18 1C overnight. In the next step, bacteria
were harvested by centrifugation at 10 000 rpm for 30 min.
Then, the pellet was resuspended in lysis buffer (25 mM
Na2HPO4, 150 mM NaCl, 20 mM PMSF, 1% Triton, and pH 8.8)
and sonicated (10 min of pulse 30 s of 40% amplitude). Finally,
the lysate was centrifuged at 14 500 rpm for 30 min, and the
supernatant was kept.
Following the expression of the fusion protein ATP7B
MBD3–4-intein, there is a crucial need to purify the native
ATP7B MBD3–4. Therefore, the lysate was loaded on the chitin
bead column allowing the ATP7B MBD3–4-intein to bind to the
resin via its chitin-binding tag. Then, the resin was washed with
50-column volumes of lysis buffer. Next, 5 ml dithiothreitol
(50 mM DTT) was added and incubated for 48 h at 4 1C to perform
a self-cleavage of the intein. As the final step, elution fractions
were collected from the column using the chitin column buffer
(pH = 8.8) and checked by 14% tricine SDS-PAGE.
Spin labeling
The spin-labeling process (Scheme S1 of the ESI†) was per-
formed in the presence of Cu(I) ions in order to prevent spin-
labeling of cysteine residues that are involved in Cu(I) binding.
Before labeling, 10 mM DTT was added to the protein solution
and mixed overnight at 4 1C. DTT was dialyzed out using 1 kDa
dialysis cassettes (Pierce). Next, 0.25 mg of S-(2,2,5,5-tetra-
methyl-2,5-dihydro-1H-pyrrol-3-yl)methyl methanesulfonothioate
(MTSSL, TRC) dissolved in 15 ml dimethyl sulfoxide (DMSO,
Bio lab) was added to 0.75 ml of 0.01 mM protein solution
(20-fold molar excess of MTSSL). The protein solution was then
vortexed overnight at 4 1C. The free spin label and Cu(I) ions
were removed by several dialysis cycles over 4 days. The mass of
the spin-labeled protein was confirmed by a mass spectro-
meter, and the concentration was determined by a BCA assay.
The final spin-labeled protein concentration was between
0.01 and 0.03 mM.
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Atox1 expression, purification and spin labeling is similar
to the expression of ATP7B and was described in a series of
publications.21–23
Cu(I) addition
After spin-labeling and all the dialysis steps were carried out for
removal of free spin labels from the solution, no Cu(I) ions
were found in the apo-protein solution. This was verified by
adding 0.1 mM KCN to the solution and acquiring the CW-EPR
spectra. When no Cu(I) ions are in the solution, the spectra of
the apo-protein in the presence and absence of KCN is similar
and different from those of the holo-protein.
For EPR measurements: Cu(I) (tetrakis(acetonitrile) copper(I)
hexafluorophosphate) was added to the protein solution under
nitrogen gas to preserve anaerobic conditions. No Cu(II) EPR
signal was observed at any time.
Q-band DEER measurements
The DEER experiment p/2(nobs)  t1  p(nobs)  t0  p(npump) 
(t1 + t2  t0)  p(nobs)  t2  echo was carried out at 50  0.2 K
on a Q-band Elexsys E580 spectrometer (equipped with a 2 mm
probe head). A two-step phase cycle was employed on the first
pulse. The echo was measured as a function of t0, whereas t2
was kept constant to eliminate relaxation effects. The observer
pulse was set at 60 MHz higher than the pump pulse. The
durations of the observer p/2 and p pulses were 40 ns each. The
duration of the p pump pulse was 40 ns as well, and the dwell
time was 20 ns. The power of the 40 ns p pulse was 20.0 mW.
The value t1 was set to 200 ns and t2 to 1200 ns. Observer
frequency: 33.83 GHz; pump frequency: 33.89 GHz; magnetic
field: 12 030 G. The samples were measured in 1.6 mm capillary
quartz tubes (Wilmad-LabGlass). The data were analysed using
the DeerAnalysis 2016 program, with Tikhonov regularization.25
We optimized the regularization parameter in the L curve by
examining the fit of the time domain signal. The modulation
depth for the two spin systems was about 6%.
Model building and molecular dynamics simulations
First, we prepared MBD3 and MBD4, both in the apo and holo
states. The models were built based on their NMR structure in
the apo form (PDB ID 2ROP).18 To create the Cu(I)-bound
systems, we superimposed both MBDs to one monomer of the
Atox1 homodimer X-ray structure, which contains a Cu(I) bound
between the two monomers (PDB ID 1FEE).15 Since MBD3–4 are
structurally very similar to Atox1 and share the same MXCXXC
motif, we also adopted the same position of Cu(I), observed in
Atox1, for MBD3/4.
Next, we built 6 additional systems, in which Cu(I)-bound
Atox1 formed dimers with apo MBD3 and 4, considering their
Cys268/370 and Cys271/373 residues either in the protonated or
deprotonated form. Namely, the cysteine (Cys) residues binding
Cu(I) in Atox1 were considered in a deprotonated form, whereas
the ones on MBD3/4 were considered either in protonated or
deprotonated forms. Conversely, in the simulations of the apo
systems, all Cys residues were protonated. Protonation states of
other ionizable residues were controlled with propKa.26
All models were relaxed by performing classical MD (cMD)
simulations using an Amber parm14SB-ILDN force field for
treatment of the protein.27 For the Cu(I) and Cys residues
coordinating it, we used parameters from Op’t Holt and
Merz.28 Monomeric systems were neutralized by addition of
8, 7, 1 and 0 Na+ ions for holo MBD4, apo MBD4, holo MBD3
and apo MBD3, respectively. The systems containing Atox1–
MBD3/4 complexes were neutralized by the addition of 8, 1, 10,
3, 7 and 0 Na+ ions for holo Atox1–MBD4 with protonated C370
and C373, holo Atox1–MBD3 with protonated Cys268 and C271,
apo Atox1–MBD4, apo Atox1–MBD3, holo Atox1–MBD4 with
deprotonated C370 and C373 and holo Atox1–MBD3 with
deprotonated C268 and C271. All systems were solvated in explicit
water using the TIP3P model.29 The resulting models counted
B25 000 and B50 000 to 58 000 atoms for the two monomers and
the two heterodimers, respectively.
Berendsen barostat and Langevin thermostats were used for
controlling pressure and temperature.30,31 Particle mesh Ewald
has been used to treat long-range electrostatics, and the time
step in simulations was 2 fs. We used the Amber18 code32 cuda
program. After a careful equilibration, based on the geometry
optimization and gentle heating in the NVT ensemble, 200 ns of
cMD simulations were performed.
A cluster analysis was performed with the cpptraj tool of
Ambertools18 on the cMD trajectory. The most representative
frames extracted from the MD trajectory were used as
starting structures for QM/MM (i.e., quantum mechanics (Born
Oppenheimer)/molecular mechanics) MD simulations, using
the CP2K code.33,34 This method treats part of the system at
the QM level, usually the metal binding portion of the system,
whereas the remaining part of the protein, the solvent and the
counter ions are treated at the MM level. In these simulations
we considered the QM region Cu(I) and side chains of residues
coordinating it (C268 and C271 in MBD3, C370 and C373 in
MBD4, and C12 and C15 and K60 in Atox1). The QM region here
is treated at the density functional theory (DFT) level with the
BLYP exchange–correlation functional35,36 by employing a dual
Gaussian-type/plane waves basis set (GPW).37 In particular, we
used a double-z (MOLOPT) basis set38 along with an auxiliary
PW basis set with a density cutoff of 400 Ry and Goedecker–
Teter–Hutter (GTH) pseudopotentials.39,40 This level of theory
has often been used in successful QM/MM MD simulations of
biomolecules.33,41–45 The dangling bonds between the QM and
MM regions were saturated by using capping hydrogen atoms.
All QM/MM MD simulations were performed by using an
integration time step of 0.5 fs in the NVT ensemble. All systems
were initially optimized, heated to 300 K in 2 ps, and equili-
brated at 300 K without constraints for 5 ps by using a Nosé–
Hoover thermostat.
During the QM/MM MD simulations, we observed that the
Cu(I) coordination changed from tetrahedral (as in the crystal
structure) to linear bi-coordination. Therefore, we changed the
force field parameters for classical MD (by changing the refer-
ence bond lengths and angle values of the Cu(I) coordinating
residues, whereas the spring constants were kept at the same
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performed an additional 200 ns-long cMD simulation starting
from a representative snapshot taken from the QM/MM MD
simulations for all systems.
Cluster analysis using a hierarchical agglomerate approach
was performed on all systems as described before (on frames from
20 to 200 ns from simulations for all systems) and additional
RMSD and RMSF analyses (again on frames ranging from 20 to
200 ns for all systems) were performed using Ambertools18. The
cutoff for clustering was 2.5 Å for all Atox1–MBD3/4 complexes,
whereas for monomeric MBD3 and MBD4 it was 2.0 Å and 1.5 Å,
respectively.32 The electrostatic potential surface of each system
was calculated based on the corresponding structure of the
highest populated cluster using the PDB2PQR webserver.46
Figures were done with the Chimera1.12 software.47
Results
Pulsed EPR experiments (such as double electron–electron
resonance (DEER)) can measure distances between paramag-
netic probes in the nm range.48,49 The combination of pulsed
EPR with site-directed spin labelling (SDSL), where an electron
spin is introduced into diamagnetic proteins, is widely used in
biophysical research.50 The spin label, commonly attached to
cysteine (Cys) residues, is nitroxide, and the nitroxide-labelled
Cys residue is hereafter termed R1 (Scheme S1, ESI†). Among
the seven Cys residues present in MBDs3–4, four of them form
the Cu(I) binding sites, and therefore could not be spin labelled
in the presence of Cu(I) ions. Hence, spin labelling was limited
to C305 (located in the loop between b3 and a2 of MBD3), and
C358 and C431 (located in b1 and b4 of MBD4, respectively).
MBD3–4 and Atox1 proteins were expressed, purified and spin-
labeled. Fig. 2 presents the DEER distance distribution functions
for the WT–MBD3–4, MBD3–4_C431A mutant, and MBD3–
4_C305A mutant (see Fig. S1 for DEER raw data, ESI†). The latter
mutations were introduced to monitor the distance distributions
relative only to the two remaining cysteine residues, which are
spin-labelled. Hence, C305A and C431A are employed to detect
the C431R1–C358R1 and C305R1–C358R1 distance distributions
in MBD4 and MBD3–4, respectively. Owing to the low concen-
tration of the protein, the DEER time scale was acquired up to
1.2 ms; thus we could not detect the distance between C431R1
and C305R1, which is around 5.0 nm. Superposition of the
distance distribution of C431A with that of C305A agrees well
with that of the WT protein (Fig. S1, ESI†), confirming that the
structural and dynamical features of MBD3–4 are insensitive to
the C431R1–C305R1 distance contribution. The DEER data
indicate that both the C305R1–C358R1 and C431R1–C358R1
mean distances slightly increase upon Cu(I) binding. Addition-
ally, metal binding widens the distribution function of the
C305A mutant (i.e., the C431R1–C358R1 distance distribution)
with respect to the C431A mutant (i.e., the C305R1–C358R1
distance distribution). Thus, the spin labels at C431R1 are more
dynamic, underlying an enhanced motion when Cu(I) binds to
MBD4. Consistently, the flexibility of b4 also increases upon
Cu(I) binding to Atox1.21 Continuous-wave (CW) EPR experi-
ments support pulsed EPR data, and detect large amplitude
motions for the MBD3–4_C305A mutant upon Cu(I) binding
Fig. 2 (A) MBD3–4 NMR structure (PDB 2ROP) showing the three cysteine (Cys) residues accessible for spin labelling (represented in yellow), and the Cu(I)
sites in grey. C431 is missing from the PDB structure and was modelled for representation purposes. The black arrows mark the measured distances by
DEER. The DEER distance distribution functions for WT–MBD3–4 (spin-labelled at three different positions) (C431R1, C358R1, and C305R1) in the absence
(black line) and presence of Cu(I) (red line). (B) DEER distance distribution functions for MBD3–4_C305A mutant (corresponding to the C358R1–C431R1
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(Table S1, Fig. S2 and S3, ESI†). Hence, metal binding induces
internal protein rearrangements that also affect protein flexibility.
By using DEER measurements, we also explored the transient
interactions occurring between Atox1 and MBD3–4. Atox1 is a
dimer in solution, and when spin-labelled at C41R1, a bimodal
distance distribution function23 is observed (Fig. 3). Previously,
by using various distance distribution constraints, we computed
two distinct conformational states of the Atox1 homodimer,
which we called closed and open conformations.21 The distribu-
tion around 4.2 nm corresponds to a closed conformation, which
agrees with that of PDB ID 3IWX,51 while the distribution around
2.3 nm corresponds to an open conformation not yet trapped
by either NMR or X-ray crystallography.21 Interestingly, when
adding spin-labelled Atox1 to MBD3–4 solution, the distribution
around 4.2 nm disappears, suggesting that in the presence of
MBD3–4, Atox1 no longer exists as a homodimer. Cross-linking
experiments also support this conclusion (Fig. S4, ESI†). Further-
more, the additional peak appearing at 3.4  0.3 nm (a grey area
in Fig. 3) can be assigned to the formation of the MBD3–4–Atox1
complex (corresponding to the distance between C41R1 of Atox1
and C431R1/C358R1/C305R1 of MBD3–4), irrespective of Cu(I)
addition. Moreover, in the presence of Cu(I), the distance dis-
tributions are narrower, implying that the MBD3–4–Cu(I)–Atox1
complex is less dynamic, and, possibly, more tightly bound.17
Hence, in contrast to other experimental findings, our results
indicate that a complex between MBD3–4 and Atox1 can also
form in the absence of Cu(I), even though the metal contributes
to rigidification and, possibly, stabilization of the adduct. Cross-
linking experiments (Fig. S4, ESI†) confirmed that Atox1 mono-
mer binds to MBD3–4 by interacting with only one of the two
domains. To identify the MBD implicated in Atox1 binding, we
performed DEER experiments on MBD3–4_C305A in which only
MBD4 is spin-labelled. As a result, if Atox1 interacts exclusively
with MBD4, no change in the distance distribution function for
the spectra of WT and C305A–MBD3–4 should occur. Indeed,
similar broad distance distribution function (between 1.5 and
3.5 nm) detected in the two cases confirms that Atox1 probably
interacts only with MBD4 (Fig. 3). In the holo state, the distribu-
tions are narrower, and therefore it is more accurate to compare
between the two states. There, the width of the bimodal dis-
tribution of the holo C305A in the presence of Atox1 is similar to
the holo MBD3–4 in the presence of Atox1 (Fig. 3 and Fig. S1,
ESI†), confirming that no interaction between C305R1 and
C41R1 exists. It is important to note, that if Atox1 was sensitive
to MBD3, a distance between C41R1 of Atox1 and C305R1 should
be between 2.5 nm to 3.5 nm, and therefore should be detect-
able. Moreover, for holo C305A, the population of the distribu-
tion around 3.4 nm (corresponds to MBD4–Atox1 interaction) is
almost equal to the distribution around 2.3 nm that corresponds
to the distance measured in MBD4 (C358R1–C431R1) (Fig. 3 and
Fig. S1, ESI†). For WT–MBD3–4, two distances are being mea-
sured (C305R1–C358R1, C358R1–C431R1) while for MBD34–
C305A, only one distance is being measured between C431R1–
C358R1. The fact that in WT–MBD3–4 the ratio between 2.3 nm
to 3.4 nm distributions is about two, and for MBD34–C305A is
equal, suggests that Atox1 interacts with MBD4 in a way that only
one distance can be detected between C41R1 of Atox1 to MBD4
(C358R1/C431R1). Additionally, the lack of MBD3 sensitivity
to the interaction with Atox1 may indicate that the latter inter-
acts with MBD4 in a face-to-face manner rather than in the
face-to-back mode (the sandwich model) evoked by smFRET,
since only in this scenario no interaction between Atox1 and
MBD3 occur.20
Building on these experimental findings, we carried out
all-atom simulations to assess how Cu(I) binding affects the struc-
tural and dynamical properties of MBD3/4 monomers and those
of the Atox1–MBD3/4 heterodimers. To this end, we performed
200 ns-long cMD simulations in explicit solvent.
Fig. 3 DEER distance distribution functions for WT–MBD3–4 and MBD3–4_C305A as a function of spin-labelled Atox1 and Cu(I). The grey area marks
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All MBD monomers reached structural stability within a few
tens of ns, with MBD4 deviating the least from the initial
structure and displaying the lowest flexibility in both the holo
and the apo forms, as compared with MBD3 (Fig. S5 and
Table S2, ESI†). In contrast, Cu(I) binding partially rigidifies
the structure of MBD3 (Fig. S5, ESI†), while destabilizing
important structural motifs: (i) the Cu(I) loop, containing the
C268 (Cu(I)-binding residue), frequently loses its initial con-
formation (Fig. 4, Fig. S6 and Table S2, ESI†); (ii) helix a1,
containing the second Cu(I)-binding residue, C271, starts
unfolding (Fig. 4 and Fig. S6, ESI†); (iii) M266, a conserved
residue of Cu(I) loop, frequently becomes solvent exposed in
MBD3. In contrast, M368 remains packed inside the hydro-
phobic pocket in MBD4, contributing to the protein’s structural
stability (Fig. 4, Fig. S6A, B and Table S2, ESI†).
In both MBD3 and 4, b4 changes its conformation upon
Cu(I) binding, consistent with the DEER data presented in
Fig. 2. The DEER data showed a broadening in the distance
distribution function, which was detected for C305A, but not
for C431A, suggesting that b4 becomes more flexible upon Cu(I)
coordination. Thus, MBD4 appears to retain a pre-organized
tertiary structure suitable for receiving Cu(I) along its excretion
path, whereas Cu(I) binding to MBD3 alters important structural
motifs (Fig. 4B, D, and Fig. S6A, B, ESI†), possibly impacting on
an efficient Cu(I) transport.
Next, classical MD simulations were carried out on the apo
and holo Atox1 bound to apo MBD3 or 4 to inspect the structural
stability and dynamical properties of the resulting complexes.
In the apo Atox1–MBD3/4 adducts, C12/15@Atox1, C268/
271@MBD3, and C370/373@MBD4, which form the Cu(I)
binding sites, respectively, were protonated. The apo complex
involving MBD4 was stable during our simulations thanks to
hydrogen (H)-bond engaging K60@Atox1 to C373 (Fig. 5E,
Fig. S7, and Table S3, ESI†). Surprisingly, also the apo Atox1–
MBD3 complex was stable during the simulation, even if its
structure significantly differs from that of the apo Atox1–MBD4.
Here, K60@Atox1 establishes only hydrophobic interactions
with C268@MBD3 (Fig. 5F, Fig. S7 and Table S3, ESI†). Thus,
in contrast to experiments, cMD simulations predict that even
the apo adduct involving MBD3 is stable.
When simulating the holo adducts, force field-based MD,
which relies on predefined empirical parameters, does not
allow one to simulate directly bond breaking and formation,
and hence the rearrangements of the metal’s coordination
sphere, which may occur upon Cu(I) binding and during its
delivery from Atox1 to MBD3/4.52 Therefore, in the simulations
of the holo adducts, we needed to assess a priori the Cu(I)
coordination bonds, keeping these unvaried during the MD
simulations. In the face-to-face model of adducts that we
considered here, Cu(I) was bound to Atox1, mimicking, in this
manner, the short-lived encounter complex between the two
proteins.17 In the first simulations, C268/271 and C370/C373 of
MBD3 and 4, respectively, were kept protonated. Surprisingly,
Cu(I) binding to Atox1 affected the structural flexibility of the
heterodimer involving MBD4, resulting in the two most populated
cluster structures as extracted from the MD trajectory (Table S3,
ESI†). Among these, the structure of the most representative
cluster appears suitable for Cu(I) trafficking, even though the
distance between Cu(I), coordinated to Atox1, and C370/C373 of
the MBD4 metal binding site, which should receive Cu(I) along the
trafficking route, is too large to allow Cu(I) binding (Fig. 5A, 6C
and Table S3, ESI†). This is most likely due to the neutral state of
C370/C373, which does not allow these residues to establish
strong electrostatic interactions with Cu(I). The H-bond between
K60@Atox1 and C373@MBD4, stabilizing the apo heterodimer,
vanishes here (Fig. 5A). In the corresponding complex with
MBD3 a1, an essential structural element starts unfolding
(Fig. 5B), and the distance between Cu(I) and C268/C271 is even
larger than in MBD4 (Fig. 6D), making Cu(I) transfer to MBD3
even more unlikely than to MBD4. Moreover, the binding of
Fig. 4 Structures of the most populated clusters of MBD3/4. (A) Holo
MBD4. Secondary structure motifs a1, a2 and b1–4 are labelled. (B) Holo
MBD3. (C) Apo MBD4. (D) Apo MBD3. Cu(I) is shown as an orange sphere;
sulphur and hydrogen atoms are in yellow and white, respectively. Carbon
atoms are shown in the colour scheme of the protein. The Cu loop and
a1 are shown in opaque, whereas the rest of the protein is shown as
transparent new cartoon representation.
Fig. 5 Representative structures of holo and apo Atox1 in complex with
MBD3/4. (A) Holo Atox1–MBD4. (B) Holo Atox1–MBD3. (C) Holo Atox1–
MBD4 with deprotonated C370 and C373. (D) Holo Atox1–MBD3 with
deprotonated C268 and C271. (E) Apo Atox1–MBD4. (F) Apo Atox1–MBD3.
Cu(I) is shown as an orange sphere; sulphur, nitrogen, and hydrogen atoms
are in yellow, blue and white, respectively. Carbon atoms are shown in the
colour scheme of the protein. The Cu loop and a1 in Atox1 and MBD3/4 are
shown in opaque, whereas the rest of the protein is shown as transparent
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Cu(I) to Atox1 significantly increased per-residue flexibility
across the whole heterodimer (Fig. 6B).
Cu(I) delivery from Atox1 to MBD4/MBD3 would require the
formation of direct interactions between Cu(I) and the receiving
cysteine residues of the metal binding site. Since these distances
are larger in the complex involving MBD3, a possible Cu(I)
delivery from Atox1 to protonated MBD3 may be more unlikely
than to MBD4.
However, during Cu(I) transport it is likely that C370/C373
will spontaneously deprotonate or their deprotonation will be
co-adjusted by Cu(I) binding. In order to assess how the
protonation of Cys residues of the MBD3/4’s Cu(I) binding
motif could impact on the stability of the adducts, we finally
considered the holo Atox1–MBD3/4 complexes with deproto-
nated (depr) C268/271@MBD3 and C370/373@MBD4 residues.
This allows mimicking a more advanced step in the Cu(I)
delivery path at which the formation of a tri-coordinated state
may take place. We remark, however, that an explicit coordina-
tion bond between the Cu(I) and Cys residues of the metal
binding site is absent in cMD runs. Thus, the interactions
between Cu(I) and C268/271 and C370/373 of MBD3/4, respec-
tively, are purely based on electrostatics.53
In these simulations, the flexibility of the Atox1–Cu(I)–MBD4depr
complex lowered, especially in the Cu(I)-binding region of both
proteins, resulting in a predominant structure in the MD trajectory
with Cu(I) bound by two Cys residues of Atox1 and strongly
interacting with C373 of MBD4 (Fig. 5C, 6A and Table S3, ESI†).
Conversely, deprotonation of C268 and C271 of MBD3 increases the
flexibility of the Atox1–Cu(I)–MBD3depr complex, determining a split
of the trajectory into three major clusters, bearing Cu(I) bound by
two Cys residues from Atox1 and strongly interacting with C268 of
MBD3. Per-residue flexibility of all regions of this heterodimer was
lower compared to the neutral Atox1–Cu(I)–MBD3 complex, while
being still higher than in the Atox1–Cu(I)–MBD4depr complex
(Fig. 6A and B). As explained above, in order to have Cu(I) transfer
the cysteine residues of the metal binding site should also lie at
a favorable distance from Cu(I) in order to coordinate Cu(I).
While C268@MBD3 and C373@MBD4, both lie at comparable
distances from Cu(I), the C370@MBD4 is remarkably closer
than C271@MBD3. Hence, Cu(I) delivery may be more likely
towards MBD4 (Fig. 6C and D).
Indeed, C271@MBD3 frequently H-bonded to K60@Atox1 and
Atox1–Cu(I)–MBD3depr also manifested a loss of a1’s secondary
structure content (Fig. 5D, Fig. S8C, D and Table S3, ESI†),
possibly as a result of this interaction. Therefore, and based
on the experimental results, it is tempting to suggest that the
loss of this structural motif may adversely affect the formation
of the Atox1–Cu(I)–MBD3depr complex.
Nevertheless, cMD simulations show that, although the orien-
tation of MBD3 is possibly disfavored to accept Cu(I) delivery from
Atox1, the Atox1–MBD3 adducts are all stable, in contrast to
experimental results.
Fig. 6 Per-residue RMSF plots of MBD4, (A) during the 200 ns of MD simulations (black – holo Atox1–MBD4, protonated Cys370 and 373; green – apo
Atox1–MBD4; violet – holo Atox1–MBD4, deprotonated Cys370 and 373) and MBD3 (B) during the 200 ns of cMD simulations (red – holo Atox1–MBD3,
protonated Cys268 and 271; blue – apo Atox1–MBD3; orange – holo Atox1–MBD3, deprotonated Cys268 and 271). Regions flanking the Cu(I)-binding
residues in Atox1 and MBD3/4 are marked in yellow. Distribution of distances between Cu(I) cysteine residues of MBD4 (C) and MBD3 (D) in the
complexes of holo Atox1 with MBD3/4 considering for the latter the protonated and deprotonated cysteine residues (blue – distance between Cu(I) and
protonated S@Cys370/268; cyan – distance between Cu(I) and protonated S@Cys373/271; violet – distance between Cu(I) and deprotonated S@Cys370/
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Conclusions
In summary, the combined use of EPR measurements and MD
simulations shows that Atox1 can interact with MBD3–4 in the
apo form, even if the Atox1–MBD4 heterodimer appears to be
more consistent with a faster metal transport. The EPR data
suggest that Atox1 prefers to bind to MBD4 in a monomeric
state, and not to MBD3. MD simulations reveal that in both
holo encounter complexes only MBD4 retains complete struc-
tural integrity and the distances between Atox1–Cu(I) and the
cysteine residues of the metal binding site of MBD4 are at
shorter distances than those of MBD3, considering them either
in the protonated or deprotonated form, suggesting that MBD4
may be more likely involved in the transport route. Moreover,
Cu(I) binding also has an impact on the fold and on the
flexibility of MBD3, which makes its attendance in the metal
extrusion path more unlikely. However, in contrast to experi-
ments, which did not probe isolated Atox1–MBD3 and Atox1–
MBD4 systems, cMD simulations suggest that all heterodimers
involving MBD3 and MBD4 are stable.
EPR evidence also indicates that the Atox1 monomer binds
to MBD4 in a face-to-face manner and that it is not sandwiched
between MBD3 and MBD4. This mechanism is strikingly dif-
ferent from the acquisition path where Ctr1 delivers Cu(I) to the
Atox1 homodimer,20 suggesting that the Atox1 homodimer
breaks only upon interaction with ATP7B. Our outcomes pro-
pose that the Cu(I) extrusion path is most likely mediated by
Atox1 binding to MBD4 of ATP7B. This is most probably due to
(i) reduced flexibility of the Atox1–Cu(I)–MBD4depr heterodi-
mer, and (ii) partial unfolding of the metal binding loop and its
flanking residues, upon metal binding to MBD3 and upon
interaction with Atox1.
Since Cu(I) transport is believed to occur via the formation of
a metastable transient intermediate, maintaining and selecting
a conformation which allows an optimal interaction between
the metallochaperone and its partner ATPase is required for
efficient Cu(I) extrusion.
Despite their structural similarity, our outcomes reveal that
separate MBDs in ATP7B play distinct roles and emphasise that
Atox1 carefully regulates the in-cell Cu(I) concentration by
adopting a conformation and a monomeric/dimeric structure
specific to its interacting protein.
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